GPT and anemia: Eight treatment‐related TEAEs of Grade ≥3 severity occurred in 7/44 (15.9%) patients: 1 instance (2.3%) each of anemia, punctate keratitis, diarrhea, stomatitis, ALT increased, AST increased, decreased appetite, and hematuria.